While COVID-19 dominates the news cycle, a battle is being fought over a deadly drug that has killed over 3.7 million children and at least 24 women. The drug is Mifeprex — commonly known as the abortion pill. On July 13, an Obama-appointed federal judge enjoined the Food and Drug Administration requirements governing the prescription of Mifeprex. He ruled that requiring pregnant women to complete an in-clinic appointment to procure the drugs was a “substantial obstacle” to abortion and was to be suspended during the COVID-19 pandemic. This ruling suspends, for the abortion pill, the Risk Evaluation and Mitigation Strategy (REMS), the FDA’s rules for “certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks.” Women procuring abortion drugs without proper education or evaluation are at greater risk of complications and death due to undiagnosed ectopic pregnancy, hemorrhaging, infection, and more. This dangerous judicial activism should compel elected officials, entrusted with the care of their constituents, to take a stand when federal agencies jeopardize public health and safety.
The first drug in the abortion-pill regimen, Mifeprex was approved by the FDA in 2000 after a highly politicized scramble within the Clinton administration. Beverly Winikoff is the founder of one of the abortion pill’s loudest proponents, Gynuity Health Projects. Winikoff claimed that the September 11 terrorist attacks “saved” Mifeprex because the nearly 3,000 Americans killed that day overshadowed news of a woman killed by the abortion pill a day prior. Mifeprex was designed specifically to kill the developing child and is approved for use up to ten weeks, at which point a child has arms, eyelids, toes, fingers, and organs.
Since the drug’s approval, over 4,000 adverse maternal reactions have been reported to the FDA. The FDA acknowledges that adverse reactions are notoriously underreported, and most women experiencing hemorrhaging and severe infections will seek follow-up care at emergency rooms instead of returning to the abortion clinic. Yet emergency rooms are not required to report adverse reactions. And as of 2016, the Obama administration changed the requirement so that abortion-pill manufacturers must report only maternal deaths to the FDA. The number of women seeking blood transfusions and emergency intervention is likely much greater than 4,000.
The Mifeprex regimen has unleashed horrors on America’s women and children while providing no medical benefit. Killing innocent children, endangering mothers, and abusing the health-care system to do harm is tragic. And as long as this deadly drug remains on the U.S. market, it will pose a serious health risk.
Pregnancy is not a disease and abortion is not health care. The abortion pill is not medicine. No child deserves to be killed by a drug, and pregnant women deserve better. FDA commissioner Stephen Hahn should acknowledge the subversion of the abortion industry and its allies, which are using a national pandemic to instigate abortion expansions that could remain long after the pandemic is over. The FDA should protect the public health of Americans and pull this lethal drug, Mifeprex and its approved generics, from the market immediately.
Ted Cruz is a U.S. senator from Texas and a member of the Senate Committee on the Judiciary. Lila Rose is the president and founder of Live Action, a nonprofit human-rights organization educating on abortion and the abortion industry.